Global NGS-based AMR Detection Market Size is projected to Reach USD 1650.5 Million by 2035 | CAGR of 7.21%
Category: HealthcareGlobal NGS-based AMR Detection Market Size is projected to Reach USD 1650.5 Million by 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global NGS-based AMR Detection Market Size is expected to Grow from USD 767.5 Million in 2024 to USD 1650.5 Million by 2035, at a CAGR of 7.21% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global NGS-based AMR Detection Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Instruments & Platforms, Reagents & Consumables, and Bioinformatics & Software Solutions), By Technology (Whole-Genome Sequencing (WGS) and Targeted NGS), By Application (Clinical Diagnostics, Public Health & Surveillance, Pharma/R&D and Academic & Research Use), By End User (Hospitals & Clinical Laboratories, Public Health Agencies & Reference Labs, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/ngs-based-amr-detection-market
The NGS-based AMR detection market refers to the worldwide industry involving the use of high-throughput sequencing technologies (WGS, tNGS, mNGS) to rapidly identify resistance genes and mutations in pathogens. NGS-based antimicrobial resistance detection is an advanced and culture-independent molecular technique in which next generation sequencing (NGS) is used for identifying antibiotic resistance genes, mutations, and resistant bacteria directly from clinical or environmental samples. An emergence of global health bodies like the WHO’s Global Action Plan on AMR, along with an increasing prevalence of antimicrobial resistance AMR is propelling the NGS-based AMR detection market. Further, the integration of AI-driven bioinformatics and cloud-based analytics for accelerating and improving the accuracy of NGS-based AMR detection is escalating the market growth. However, limited standardization and data interpretation complexity, as well as increased price, technical limitations, and need for trained workforce are restraining the market.
The instruments & platforms segment dominated the market with around 55.7% share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product type, the NGS-based AMR detection market is divided into instruments & platforms, reagents & consumables, and bioinformatics & software solutions. Among these, the instruments & platforms segment dominated the market with around 55.7% share in 2024 and is projected to grow at a substantial CAGR during the forecast period. AmrProfiler is a comprehensive tools with specialized modules identifying acquired AMR genes, resistance-associated mutations, and rRNA gene mutations across nearly 18 000 bacterial species. Ongoing advancements in sequencing technology supporting precise identification of resistance genes and mutations is driving the market.
The whole-genome sequencing (WGS) segment accounted for the largest market share of nearly 72.0% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the technology, the NGS-based AMR detection market is divided into whole-genome sequencing (WGS) and targeted NGS. Among these, the whole-genome sequencing (WGS) segment accounted for the largest market share of nearly 72.0% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Whole-genome sequencing relies on NGS technologies, commonly employed for analyzing the genomes of single bacterial isolates. An upsurging need for comprehensive and high-resolution profiling of antimicrobial resistance gene across diverse pathogens is responsible for driving the market demand.
The clinical diagnostics segment dominated the market with about 55.0% share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the application, the NGS-based AMR detection market is divided into clinical diagnostics, public health & surveillance, pharma/R&D and academic & research use. Among these, the clinical diagnostics segment dominated the market with about 55.0% share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Key applications of NGS-based AMR detection in clinical diagnostics include metagenomic next-generation sequencing (mNGS), whole genome sequencing, genomic prediction, and infection control. Use of NGS technologies for precise identification of antimicrobial resistance profiles, with an increasing prevalence of MDR is driving the market demand.
The hospitals & clinical laboratories segment held the largest market share of nearly 52.0% in 2024 and is expected to grow at a significant CAGR during the forecast period.
Based on the end user, the NGS-based AMR detection market is divided into hospitals & clinical laboratories, public health agencies & reference labs, pharmaceutical & biotechnology companies, and academic & research institutes. Among these, the hospitals & clinical laboratories segment held the largest market share of nearly 52.0% in 2024 and is expected to grow at a significant CAGR during the forecast period. Clinical and public health microbiology labs are using next generation sequencing (NGS) technology into their current diagnostic cycles more frequently as a result of the technology’s quick advancements. An increasing investments in advanced NGS platforms and associated consumables aids in driving market growth.
North America is expected to hold the majority share of the global NGS-based AMR detection market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of over 30.0% in the global NGS-based AMR detection market during the forecast period. The United States is dominating the North America region in the NGS-based AMR detection market, driven by aggressive national efforts for combating antimicrobial resistance and collaborations under the National Action Plan for Combating Antibiotic-Resistant Bacteria. North America has a robust market ecosystem that includes both innovative entrepreneurs and significant industrial titans. The regions’ increasing prevalence of MDR infections, increased infrastructure investment, and need for rapid, precise diagnostic tools are also responsible for driving the market.
Asia Pacific is anticipated to grow at the fastest pace of 7.2% CAGR in the global NGS-based AMR detection market during the forecast period. India is the fastest growing country in the Asia Pacific NGS-based AMR detection market, with a CAGR of about 7.8% during the forecast period, due to the expanding genomic surveillance programs and an increasing adoption of next-generation sequencing in clinical and public health laboratories. In the Asia Pacific NGS-based AMR detection market, an increasing investment in genomic infrastructure, along with the adoption of molecular diagnostics in emerging economic countries. Initiatives such as Asia Pathogen Genomics Initiatives and India’s National Action Plan focuses on using NGS for rapid pathogen detection and evidence based policy are promoting the market growth.
Major vendors in the global NGS-based AMR detection market are Illumina, QIAGEN, Thermo Fisher Scientific, BIOMÉRIEUX, Abbott, ACRO Biosystems, CD Genomics., Diagnostics Longwood SL, Credence Genomics, Fraunhofer IGB, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In February 2026, Genient, a Noida-based genomics and molecular diagnostics company, is strengthening India’s precision healthcare ecosystem by delivering platform agonistic, India-relevant molecular and next-generation sequencing (NGS) solutions tailored to the country’s real disease burden, including antimicrobial resistance (AMR).
- In September 2024, Cepheid announced an important partnership with the Fleming Initiative, a global collaboration established by Imperial College Healthcare NHS Trust and Imperial College London to combat antimicrobial resistance.
- In April 2022, OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced that its subsidiary, Ares Genetics, which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), is commercially launching a series of new genome sequencing and analysis services globally.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the NGS-based AMR detection market based on the below-mentioned segments:
Global NGS-based AMR Detection Market, By Product Type
- Instruments & Platforms
- Reagents & Consumables
- Bioinformatics & Software Solutions
Global NGS-based AMR Detection Market, By Technology
- Whole-Genome Sequencing (WGS)
- Targeted NGS
Global NGS-based AMR Detection Market, By Application
- Clinical Diagnostics
- Public Health & Surveillance
- Pharma/R&D
- Academic & Research Use
Global NGS-based AMR Detection Market, By End User
- Hospitals & Clinical Laboratories
- Public Health Agencies & Reference Labs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Global NGS-based AMR Detection Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?